Aging is tightly associated with chronic inflammation, which has been identified as both a key contributor to the initiation and progression of Alzheimer`s disease and a compelling therapeutic target.
Neuroactive steroid hormones are potent endogenous neuromodulators affecting complex behaviors including anxiety and depression, altering susceptibility to neuropsychiatric disease and have been implicated in cognitive aging.
Obesity, metabolic syndrome and diabetes are leading global health issues with growing evidence that metabolic abnormalities at midlife may increase the risk of cognitive decline and Alzheimer`s disease in later life.